International Clinical Trial: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000865415) titled 'A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers' on Aug. 11.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Type of endpoint: Safety

Primary Sponsor: Sunterra Bio

Condition: Idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis Respiratory - Other respiratory disorders / diseases

Intervention: The study is a randomized, double-blind, placebo-con...